Publication

The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe.

Journal Paper/Review - Oct 18, 2022

Units
PubMed
Doi
Contact

Citation
Mocroft A, Geressu A, Béguelin C, Llibre J, Lazarus J, Tomazic J, Smidt J, Parczewski M, Brännström J, Sedlacek D, Degen O, van der Valk M, Paduta D, Flamholc L, Schmid P, Orkin C, Nielsen L, Hoffmann C, Beniowski M, Oprea C, Begovac J, Peters L. The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe. AIDS 2022; 37:91-103.
Type
Journal Paper/Review (English)
Journal
AIDS 2022; 37
Publication Date
Oct 18, 2022
Issn Electronic
1473-5571
Pages
91-103
Brief description/objective

There are limited data on end-stage liver disease (ESLD) and mortality in people with HIV (PWH) coinfected with both hepatitis B virus (HBV) and hepatitis C virus (HCV).